BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16156346)

  • 21. Statin treatment of rheumatoid arthritis: comment on the editorial by Ridker and Solomon.
    Peters MJ; Nurmohamed MT; Kitas GD; Sattar N
    Arthritis Rheum; 2010 Jan; 62(1):302-3. PubMed ID: 20039426
    [No Abstract]   [Full Text] [Related]  

  • 22. Study stirs debate about statin use in those without high cholesterol.
    Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535
    [No Abstract]   [Full Text] [Related]  

  • 23. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins' role in prevention. Do statins have a role in primary prevention of cardiovascular events?
    Can Fam Physician; 2004 Aug; 50():1091. PubMed ID: 15455806
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
    [No Abstract]   [Full Text] [Related]  

  • 27. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 28. Are statin effects mediated through, or in spite of, their cholesterol-lowering action?
    Mascitelli L; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(2):262-3. PubMed ID: 19141486
    [No Abstract]   [Full Text] [Related]  

  • 29. Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.
    Blum S; Milman U; Shapira C; Miller-Lotan R; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):e18-20. PubMed ID: 18296583
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients.
    Howes LG
    Diabetes Obes Metab; 2006 Jan; 8(1):8-14. PubMed ID: 16367877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Statins in older patients: limits to prescription?].
    Bosshard Taroni W; Büla C; Darioli R
    Rev Med Suisse; 2005 Nov; 1(39):2512-4, 2516-7. PubMed ID: 16323731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipid metabolism disorders in children and the elderly. Therapy at the fringes of the indication range].
    Klose G
    MMW Fortschr Med; 2008 Nov; 150(47):30. PubMed ID: 19189452
    [No Abstract]   [Full Text] [Related]  

  • 34. Statin use and the risk of developing diabetes. Study confirms a link, but does the risk outweigh the benefits?
    Johns Hopkins Med Lett Health After 50; 2012 Apr; 24(2):1-2. PubMed ID: 22550723
    [No Abstract]   [Full Text] [Related]  

  • 35. Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control.
    Hobbs FD
    Int J Cardiol; 2006 Jun; 110(2):137-45. PubMed ID: 16289373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary prevention of cardiovascular disease with statins: cautionary notes.
    Goldstein MR; Mascitelli L; Pezzetta F
    QJM; 2009 Nov; 102(11):817-20. PubMed ID: 19620217
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy and clinical trials.
    Devendra GP; Krasuski RA
    Curr Opin Lipidol; 2010 Oct; 21(5):471-2. PubMed ID: 20827082
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of dyslipidemia in diabetes.
    Solano MP; Goldberg RB
    Cardiol Rev; 2006; 14(3):125-35. PubMed ID: 16628021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study.
    Fu AZ; Zhang Q; Davies MJ; Pentakota SR; Radican L; Seck T
    Curr Med Res Opin; 2011 May; 27(5):1035-40. PubMed ID: 21410303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.